Rapid Growth Prompts Expansion for Technimark Healthcare

Prompted by rapid growth of its healthcare business, Technimark broke ground on an 80,000-square-foot addition to its Latrobe, Pa. healthcare manufacturing facility, nearly doubling the size of its existing plant there.

This content was submitted directly to this website by the supplier.

Prompted by rapid growth of its healthcare business, Technimark
broke ground on an 80,000-square-foot addition to its Latrobe, Pa. healthcare manufacturing
facility, nearly doubling the size of its existing plant there. The company announced a similar
expansion at its El Paso, TX facility.
Technimark is a global manufacturer of custom rigid plastic solutions for the consumer
packaging, healthcare and industrial markets, and is owned by PPC Partners along with
management.
At a recent groundbreaking ceremony at the Pennsylvania plant, Technimark officials said the
expansions are needed to meet increasing demand for the services of its healthcare division.
“A key element in our business strategy is a commitment to ensure we have state-of-the-art
facilities and services that allow us to serve our customers’ current and future manufacturing
needs,” said Brad Wellington president and CEO. “Our expansions in Latrobe and El Paso are
examples of that commitment. Over the past few years, we have built or expanded a number of
ISO-certified cleanrooms in Pennsylvania, Texas, Mexico, the United Kingdom, and China.”
Technimark acquired Latrobe-based Ci Medical Technologies, a top manufacturer of injectionmolded
components used in medical, pharmaceutical and consumer healthcare products, in
2015. The company’s healthcare division currently produces a variety of specialty medical
components and finished medical devices for various key healthcare markets, including surgical,
diagnostics, life science, pharmaceutical and consumer healthcare, among others.
According to John Rugari, vice president of sales for Technimark Healthcare, the company
currently serves customers worldwide from 14 manufacturing facilities across North America,
Europe and Asia. “Our value proposition is resonating strongly in the healthcare market and, as
a result, our pipeline of new contracts from our strategic customers and new customers is
exceptionally strong. That robust pipeline is driving our growth and need for expansions around
the world,” Mr. Rugari said. He noted Technimark Healthcare facilities meet all applicable ANSI
and ISO 9001 and ISO 13485 standards, as well as all relevant FDA regulations for the
manufacture of medical products.

More in Home